• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性前列腺癌放射性核素骨扫描中的闪烁现象。

The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.

作者信息

Pollen J J, Witztum K F, Ashburn W L

出版信息

AJR Am J Roentgenol. 1984 Apr;142(4):773-6. doi: 10.2214/ajr.142.4.773.

DOI:10.2214/ajr.142.4.773
PMID:6230903
Abstract

The radionuclide bone scan 3 months after the initiation of treatment for advanced cancer of the prostate occasionally shows apparent progression of individual lesions despite clinical improvement. To determine the incidence and clinical significance of this so-called flare phenomenon, serial bone scans were reviewed in 33 patients with carcinoma of the prostate and bony metastases, who were receiving endocrine treatment for the first time. A flare reaction was seen in two (6%) of 33 bone scans obtained 3 months after initiation of treatment. A flare reaction on bone scan is an unusual phenomenon in prostatic cancer; in general, serial scans accurately depict the activity of bony metastases in these patients.

摘要

在晚期前列腺癌治疗开始3个月后的放射性核素骨扫描,偶尔会显示尽管临床症状有所改善,但个别病灶却有明显进展。为了确定这种所谓的闪烁现象的发生率及临床意义,我们回顾性分析了33例首次接受内分泌治疗的前列腺癌伴骨转移患者的系列骨扫描结果。在治疗开始3个月后所进行的33次骨扫描中,有2次(6%)出现了闪烁反应。骨扫描出现闪烁反应在前列腺癌中是一种不常见的现象;一般来说,系列扫描能够准确描绘出这些患者骨转移灶的活性。

相似文献

1
The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.转移性前列腺癌放射性核素骨扫描中的闪烁现象。
AJR Am J Roentgenol. 1984 Apr;142(4):773-6. doi: 10.2214/ajr.142.4.773.
2
[Flare response on bone scintigraphy in metastatic prostate cancer].[转移性前列腺癌骨闪烁显像的耀斑反应]
Nihon Hinyokika Gakkai Zasshi. 1994 May;85(5):815-8. doi: 10.5980/jpnjurol1989.85.815.
3
Accumulation of a bone imaging agent in liver metastases from prostate carcinoma.一种骨显像剂在前列腺癌肝转移灶中的蓄积。
Clin Nucl Med. 1983 Oct;8(10):488-9.
4
Metastatic prostatic pulmonary nodules with normal bone image.骨影像正常的转移性前列腺肺结节
J Nucl Med. 1983 Nov;24(11):1026-7.
5
The assessment of response to therapy of bone metastases in breast cancer.乳腺癌骨转移治疗反应的评估
Aust N Z J Med. 1984 Feb;14(1):19-22. doi: 10.1111/j.1445-5994.1984.tb03578.x.
6
How significant are serial bone scans in monitoring advanced prostatic cancer?连续骨扫描在监测晚期前列腺癌方面的意义有多大?
Int Urol Nephrol. 1995;27(1):87-91. doi: 10.1007/BF02575225.
7
Optimizing the performance and interpretation of bone scans.优化骨扫描的性能与解读
Clin Nucl Med. 1981 Oct;6(10S):P68-76. doi: 10.1097/00003072-198110001-00012.
8
[Skeletal scintigraphy for the observation of course and treatment of carcinoma of the prostate ].[骨闪烁显像用于观察前列腺癌的病程及治疗]
Rofo. 1981 Jul;135(1):44-9. doi: 10.1055/s-2008-1056828.
9
Super bone scan in metastatic stomach cancer.转移性胃癌中的超级骨显像
Wis Med J. 1990 Apr;89(4):161-3.
10
Quantitative bone scan and bone metastases in prostatic cancer.前列腺癌的定量骨扫描与骨转移
Urol Int. 1985;40(1):45-7. doi: 10.1159/000281032.

引用本文的文献

1
Restaging With Prostate-Specific Membrane Antigen Imaging in Metastatic Castration-Resistant Prostate Cancer: When Seeing More Is Detrimental to Care.转移性去势抵抗性前列腺癌中应用前列腺特异性膜抗原成像进行再分期:看得更多对治疗有害。
J Clin Oncol. 2024 Jul 1;42(19):2242-2244. doi: 10.1200/JCO.23.02727. Epub 2024 Mar 15.
2
From Concept to Regulatory Drug Approval: Lessons for Theranostics.从概念到药物监管批准:诊疗一体化的经验教训
J Nucl Med. 2022 Dec;63(12):1793-1801. doi: 10.2967/jnumed.121.263301.
3
Tumor Microenvironment, Clinical Features, and Advances in Therapy for Bone Metastasis in Gastric Cancer.
胃癌骨转移的肿瘤微环境、临床特征及治疗进展
Cancers (Basel). 2022 Oct 6;14(19):4888. doi: 10.3390/cancers14194888.
4
Head-to-head comparison of Tc-PSMA and Tc-MDP SPECT/CT in diagnosing prostate cancer bone metastasis: a prospective, comparative imaging trial.Tc-PSMA 与 Tc-MDP SPECT/CT 对头对头比较诊断前列腺癌骨转移:一项前瞻性、对比成像试验。
Sci Rep. 2022 Sep 26;12(1):15993. doi: 10.1038/s41598-022-20280-x.
5
Interval Changes in PSMA PET/CT During Radium-223 Therapy for Metastatic Bone Disease from Castration-Resistant Prostate Cancer.镭-223治疗去势抵抗性前列腺癌骨转移期间PSMA PET/CT的间期变化
Nucl Med Mol Imaging. 2022 Aug;56(4):188-195. doi: 10.1007/s13139-022-00754-6. Epub 2022 Jun 8.
6
Deep Learning for the Automatic Diagnosis and Analysis of Bone Metastasis on Bone Scintigrams.用于骨闪烁扫描图上骨转移自动诊断与分析的深度学习
Cancer Manag Res. 2022 Jan 3;14:51-65. doi: 10.2147/CMAR.S340114. eCollection 2022.
7
Reliability of Alkaline Phosphatase for Differentiating Flare Phenomenon from Disease Progression with Bone Scintigraphy.碱性磷酸酶在骨闪烁显像中鉴别耀斑现象与疾病进展的可靠性
Cancers (Basel). 2022 Jan 5;14(1):254. doi: 10.3390/cancers14010254.
8
Bone Metastases from Gastric Cancer: What We Know and How to Deal with Them.胃癌骨转移:我们所了解的情况及应对方法
J Clin Med. 2021 Apr 19;10(8):1777. doi: 10.3390/jcm10081777.
9
Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imaging.前列腺癌中的耀斑现象:关于新药和新一代成像的最新证据
Ther Adv Med Oncol. 2021 Feb 24;13:1758835920987654. doi: 10.1177/1758835920987654. eCollection 2021.
10
A review of prostate cancer imaging, positron emission tomography, and radiopharmaceutical-based therapy.前列腺癌成像、正电子发射断层扫描及放射性药物治疗综述。
Can Urol Assoc J. 2020 Apr;14(4):130-138. doi: 10.5489/cuaj.6506. Epub 2020 Apr 1.